C. Haberl

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Sylvie Lorenzen, Marcus Hentrich, C. Haberl et al. · Annals of Oncology · 2007 · 132 citations · Full text

Medicine, Oncology, Pharmacology +11

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · Journal of Clinical Oncology · 2011 · 117 citations

Medicine, Oncology, Pharmacology +14

Cysteinyl Leukotriene Production in Anaphylactic Reactions

Claudio Denzlinger, C. Haberl, W. Wilmanns · International Archives of Allergy and Immunology · 2009 · 50 citations

Life Sciences, Immunology, Pharmacology +13

Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer

Monika Klinkhammer‐Schalke, Brunhilde Steinger, Michael Koller et al. · European Journal of Cancer · 2020 · 42 citations

Pharmacy, Oncology, Surgery +16

Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients

Ariane Hallermayr, Tobias Wohlfrom, Verena Steinke‐Lange et al. · Journal of Hematology & Oncology · 2022 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +17